# US 2021/0196856 A1 · Dimethylacrylamide (DMAA) Hydrogel for Expansion Microscopy (ExM)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0196856 A1
- Document ID: US20210196856A1
- Status: Published application
- Kind: A1
- Application number: 17/144,551
- Filed: 2021-01-08
- Published: 2021-07-01
- Earliest claimed: 2018-07-13
- Assignees: Massachusetts Institute of Technology
- Applicants: Massachusetts Institute of Technology
- Inventors: Edward Stuart Boyden; Nikita Obidin; Ruixuan Gao; Linyi Gao
- Web page: https://patentgrep.com/patent/US20210196856A1

## CPC

- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- C08F 220/56: Acrylamide; Methacrylamide
- C08L 33/26: Homopolymers or copolymers of acrylamide or methacrylamide
- G01N 1/312: {for samples mounted on planar substrates}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention provides a method for preparing an expanded cell or tissue sample suitable for microscopic analysis. Expanding the sample can be achieved by binding, e.g., anchoring, key biomolecules to a DMAA-TF polymer network and swelling, or expanding, the polymer network, thereby moving the biomolecules apart as further described herein. As the biomolecules are anchored to the polymer network isotropic expansion of the polymer network retains the spatial orientation of the biomolecules resulting in an expanded, or enlarged, sample.

## Claims

### Claim 1

A method for preparing an expandable tissue sample, the method comprising the steps of:
(a) incubating the sample with a composition comprising acrylamide, dimethylacrylamide, and sodium acrylate linear monomers at a concentration of about 20 about 50 wt % of which sodium acrylate comprises about 10 to about 25 mol %, about 0.1 to about 1.0 mol % polymerization initiator, about 0.005 to about 0.02 wt % polymerization inhibitor and about 0.001 to about 0.01 wt % polymerization accelerator; and
(b) polymerizing the composition within the sample to form a polymer, wherein the polymer is embedded throughout the sample.

### Claim 2 (depends on 1)

The method according to claim 1, wherein prior to incubating the sample with the composition, the sample is treated with a chemical anchoring reagent.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the chemical anchoring reagent is acryloyl-X.

### Claim 4 (depends on 2)

The method according to claim 2, wherein polymerizing results in covalent anchoring of biomolecules within the sample to the polymer to form a sample-polymer complex.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the biomolecules within the sample are anchored to the polymer during and/or after said polymerization.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the concentration of linear monomers in the composition is about 30% to about 40%.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the concentration of linear monomers is about 35%.

### Claim 8 (depends on 6)

The method according to claim 6, wherein the concentration of linear monomers is about 33%.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the sodium acrylate is about 15 to about 20 mol % of the linear monomer concentration.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the sodium acrylate is about 15 mol % of the linear monomer concentration.

### Claim 11 (depends on 9)

The method according to claim 9, wherein the sodium acrylate is about 20 mol % of the linear monomer concentration.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the composition comprises about 0.4 mol % polymerization initiator.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the polymerization initiator is potassium persulfate (KPS).

### Claim 14 (depends on 1)

The method according to claim 1, wherein the composition comprises about 0.005 wt % polymerization accelerator.

### Claim 15 (depends on 14)

The method according to claim 14, wherein the polymerization accelerator is TEMED.

### Claim 16 (depends on 1)

The method according to claim 1, wherein the composition comprises about 0.01 wt % polymerization inhibitor.

### Claim 17 (depends on 16)

The method according to claim 16, wherein the polymerization inhibitor is 4-Hydroxy-TEMPO.

### Claim 18 (depends on 1)

The method according to claim 1, wherein prior to performing the permeating step, the sample is treated with a detergent.

### Claim 19 (depends on 1)

The method according to claim 1, further comprising the step of adding an aqueous solvent or liquid to cause the sample-polymer complex to swell, thereby physically expanding the complex.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the sample-polymer complex expands isotropically.

### Claim 21 (depends on 19)

The method according to claim 19, wherein the aqueous solvent or liquid is water.

### Claim 22 (depends on 19)

The method according to claim 19, wherein prior to the step of adding the aqueous solvent or liquid to swell the sample-polymer complex, the complex is subjected to digestion.

### Claim 23 (depends on 22)

The method according to claim 22, wherein the digestion comprises incubating the complex with a composition comprising a non-specific protease.

### Claim 24 (depends on 23)

The method according to claim 23, wherein the composition comprises a non-specific protease in a buffer comprising a metal ion chelator, a non-ionic surfactant, and a monovalent salt.

### Claim 25 (depends on 24)

The method according to claim 24, wherein the composition comprises about 1 to about 100 U/ml of a non-specific protease in a buffer having a pH between about 4 and about 12, the buffer comprising about 5 mM to about 100 mM of a metal ion chelator, about 0.1% to about 1.0% of a nonionic surfactant, and about 0.05 M to about 1.0 M monovalent salt, for about 0.5 to about 3 hours at about 50° C. to about 70° C.

### Claim 26 (depends on 19)

The method according to claim 19, further comprising the step of producing a high-resolution image of the sample by viewing the enlarged sample under a microscope.

### Claim 27 (depends on 19)

The method according to claim 19, further comprising the step of optically imaging the enlarged sample by viewing the sample under a microscope.

### Claim 28

A method for preparing an expandable cell sample, the method comprising the steps of:
(a) incubating the sample with a composition comprising acrylamide, dimethylacrylamide, and sodium acrylate linear monomers at a concentration of about 20 to about 50 wt % of which sodium acrylate comprises about 10 to about 25 mol %, about 0.1 to about 1.0 mol % polymerization initiator, and about 0.001 to about 0.01 wt % polymerization accelerator; and
(b) polymerizing the composition within the sample to form a polymer, wherein the polymer is embedded throughout the sample.

### Claim at position 29

29-52. (canceled)
